+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Cirrhosis Drug"

Global Liver Cirrhosis Epidemiology and Patient Flow - 2021 - Product Thumbnail Image

Global Liver Cirrhosis Epidemiology and Patient Flow - 2021

  • Report
  • February 2021
  • Global
From
Primary Biliary Cirrhosis Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Thumbnail Image

Primary Biliary Cirrhosis Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • September 2024
  • 98 Pages
  • Global
From
Liver Cirrhosis Therapeutics Drug Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Liver Cirrhosis Therapeutics Drug Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • October 2023
  • 102 Pages
  • Global
From
Cirrhosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players - Product Thumbnail Image

Cirrhosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

  • Report
  • May 2022
  • 120 Pages
  • Global
From
Loading Indicator

Cirrhosis is a serious liver disorder caused by long-term damage to the liver. It is characterized by scarring of the liver tissue, which can lead to liver failure. Treatment for cirrhosis typically involves medications to reduce inflammation, improve liver function, and reduce the risk of complications. Drugs used to treat cirrhosis include diuretics, antibiotics, antivirals, and immunosuppressants. The cirrhosis drug market is a subset of the larger liver and kidney disorders drugs market. It is composed of drugs used to treat cirrhosis and its associated complications. These drugs are used to reduce inflammation, improve liver function, and reduce the risk of complications. Some companies in the cirrhosis drug market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more